5th International Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products

After a successful conference in 2016, Conference Series LLC is very delighted to invite you all to the “5^th International Conference on Pharmacognosy, Phytochemistry & Natural Products” (Pharmacognosy 2017) scheduled on July 24-26, 2017 at Melbourne, Australia. We are progressively working for the initiation of new world, perspectives and views in the field of pharmaceutical Sciences. Conference Series LLC is providing a great platform for thousands of pharmacists meet, learn, share and exchange views. We are concentrating on a view that everyone should gain from the conference. So, we are organizing plenary sessions, poster exhibitions and section programs, workshops at the conference.

Conference Series LLC is a world class conference organizer, which have highly talented conference organizers around the globe. We have 70,000 editorial board members for Conference Series LLC journals and also 600+ Scientific conferences. We publish more than 700+ Open access journals for which we have more than 1 million readers and we strictly follow 21 day rapid review process. We endeavor to support and organize a variety of conferences throughout the year as educational opportunities to update knowledge and skills. To know more about the conference series visit: http://conferenceseries.com/

Pharmacognosy 2017 is supported with related journals and their editorial board members which provide a chance of meeting them, along with experts in Herbal Medicine, Pharmacological sciences and Pharmaceutical sciences.

Pharmacognosy 2017 will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Pharmacognosy, Phytochemistry & Natural Products fields across the world. The pharmacognosy conference scientific program paves a way to gather latest information through the research talks and presentations and put forward many thought provoking strategies in Pharmacognosy Conference

The global market for botanical and plant-derived drugs was valued at $23.2 billion in 2013 and $24.4 billion in 2014. This total market is expected to reach $25.6 billion in 2015 and nearly $35.4 billion in 2020, with a compound annual growth rate (CAGR) of 6.6% from 2015 to 2020.